PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Higher levels of air pollution linked to worsening of sleep apnea

2025-09-28
People who have obstructive sleep apnoea (OSA) may suffer worse symptoms if they live in areas with higher levels of air pollution, according to a multi-national study presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1].   Patients with OSA often snore loudly, their breathing starts and stops during the night, and they may wake up several times. Not only does this cause excessive sleepiness, but it can also increase the risk of high blood pressure, stroke, heart disease and type 2 diabetes. OSA is very common, ...

ASTRO: New therapy delays progression of recurrent prostate cancer

2025-09-28
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT) went more than twice as long without their disease worsening compared with those who received SBRT alone, according to new clinical trial results from UCLA Health Jonsson Comprehensive Cancer Center researchers.    Findings from the trial, presented today at the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco, showed that men who received the radioligand drug ...

Low-dose radiation therapy offers substantial relief to people with painful knee osteoarthritis

2025-09-28
SAN FRANCISCO, September 28, 2025 — A single course of low-dose radiation therapy may provide a safe and effective alternative treatment option for people with painful knee osteoarthritis according to a new randomized, placebo-controlled clinical trial. The study showed patients with mild to moderate knee osteoarthritis reported significant reductions in pain and improved physical function in the four months after receiving the low dose of radiation, which was just a small fraction of what’s used to treat cancer. Because the study included a control group with simulated treatment, the researchers could distinguish ...

Radiopharmaceutical added to stereotactic radiation delays prostate cancer progression in patients with limited metastatic disease

2025-09-28
SAN FRANCISCO, September 28, 2025 — A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted radiation, compared with radiation alone. The phase II LUNAR trial is the first randomized study to show that a treatment established for later-stage prostate cancer can delay progression and defer hormone therapy when added to high-precision radiation ...

First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer

2025-09-28
SAN FRANCISCO, September 28, 2025 — A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery — the first predictive biomarker in this setting. In the first prospective, randomized trial to validate a predictive gene expression test for hormone therapy in prostate cancer, patients with a prostate tumor subtype known as luminal B had much lower risks of recurrence and metastasis when radiation was complemented by apalutamide, a type of hormone therapy. Patients without this tumor subtype, however, saw no improvement. ...

Specialised singing programmes can improve the symptoms and quality of life of people with lung disease

2025-09-28
Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomised-controlled trial presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1]. The study was presented by Professor Natasha Smallwood from Monash University, Melbourne, Australia. Professor Smallwood told the Congress: “Chronic breathlessness is a common and highly distressing symptom for people with chronic obstructive pulmonary disease and interstitial lung disease. Yet there is a lack ...

Children with asthma who use at-home monitoring are half as likely to need hospital care

2025-09-28
Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalised, compared to those who only receive care from their medical team, according to research presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands [1]. Remote monitoring also helped keep children’s symptoms under control.   At-home monitoring involved children and their families using an app approximately once a month to answer questions ...

Combination inhaler reduces asthma attacks in children by almost half

2025-09-28
Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be more effective than salbutamol, the current standard for asthma symptom relief in children, with no additional safety concerns.  The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – ...

Low-cost drug shows promise for patients with life threating respiratory infections

2025-09-28
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King’s College London. The study analysed data from almost 500 patients hospitalised with COVID-19 across six countries. Patients who inhaled heparin were half as likely to require ventilation and had a significantly lower risk of dying compared with those receiving standard care. Heparin, a drug traditionally injected to treat blood clots, was tested in this study in an inhaled form, targeting the lungs directly. As well as acting as an anticoagulant, ...

Emergency medicine workers report job satisfaction, though burnout and staff retention remain major problems

2025-09-27
Vienna, Austria: One of the largest international surveys into job satisfaction among emergency department workers has revealed that while the majority found their work satisfying and rewarding, there are still many areas where improvements are needed, according to research presented at the European Emergency Medicine Congress today (Sunday) [1]. The paper, “Global Job Satisfaction Among Emergency Medicine Professionals: Results from the 2025 Emergency Medicine Day Survey”, is published today in the European Journal ...

Eating fruit may reduce the effects of air pollution on lung function

2025-09-27
Eating fruit may reduce the effects of air pollution on lung function Eating fruit may reduce the effects of air pollution on lung function, according to research presented at the European Respiratory Society Congress in Amsterdam, the Netherlands [1]. The study was presented by Pimpika Kaewsri, a PhD student from the Centre for Environmental Health and Sustainability at the University of Leicester, UK. She explains: “Over 90% of the global population is exposed to air pollution levels that exceed WHO guidelines, and ample ...

Pulp mill waste becomes green solution to remove toxic dyes

2025-09-27
Dyes like Congo red and methyl orange create brightly hued shirts, sweaters and dresses. But these commonly used azo dyes can be toxic, carcinogenic and are hard to remove from wastewater.  David Chem, a University of Arkansas chemical engineering Ph.D. candidate, developed an environmentally friendly solution to remove these dyes using a common byproduct of the pulp and paper industry.  Azo dyes are used in 60-70% of commercial textile production. The dyes dissolve easily in water and resist biodegradation, which makes them an environmental hazard. ...

Sustainable generative AI: UCLA develops novel light-based system

2025-09-26
Today’s popular chatbots and image generators have a severe downside for the environment. These examples of generative artificial intelligence leave a substantial carbon footprint due to outsized energy demands. At the same time, the large amount of water used to cool the equipment behind generative AI depletes a finite resource that humans, other animals and plants need in order to survive. Additionally, running such models requires massive computational infrastructure, raising concerns about their long-term sustainability. Now, researchers at the UCLA Samueli School of ...

University of Phoenix publishes new white paper on microservice using achieved skills to build confidence between students and employers

2025-09-26
University of Phoenix today announced the publication of a new white paper, “Leveraging Achieved Skills to Improve Confidence Between Students and Employers,” authored by Francisco Contreras and Brandon Edwards of the University’s careers product team. The paper outlines how a record of a learners’ achievements and attested skills can help students and employers speak a common language of skills, and help working adult learners see where they may qualify—and where they are close—before they apply. “When learners can see verified, granular skills mapped from their coursework and experience—and employers can see the same—confidence ...

ASTRO: Targeted radioactive therapy for recurrent prostate cancer, new SBRT approaches, 5DCT-guided imaging advances and more

2025-09-26
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on targeted radioactive therapy for recurrent prostate cancer, new approaches to stereotactic body radiation for prostate and head and neck cancers, advances in MRI- and 5DCT-guided imaging for more precise treatments, and innovations in patient-focused cancer education. At this year’s scientific meeting, Dr. Amar Kishan, executive vice chair of radiation oncology at UCLA and co-director of ...

University of Cincinnati Cancer Center members present radiation oncology research at national conference

2025-09-26
University of Cincinnati Cancer Center researchers will present abstracts at the American Society for Radiation Oncology (ASTRO) annual meeting Sept. 27 through Oct. 1 in San Francisco. Study evaluates safety, efficacy of head and neck proton re-irradiation Patients with head and neck malignancies face a high risk of disease recurrence and the development of secondary primary cancers. While surgery is the preferred treatment in these cases, it is not always feasible based on tumor location or prior treatments. An additional course of proton radiation therapy called re-irradiation can be ...

ASTRO 2025: At 10 years, SBRT comparable to surgery for early-stage lung cancer

2025-09-26
Study is the first to compare 10-year outcomes from surgery and a specific kind of radiation therapy known as SBRT (also called SABR) in non-small cell lung cancer Survival outcomes were similar, but the SBRT group had fewer side effects and potentially less financial burden Study further confirms radiation as an alternative for these patients, even in cases where the cancer is operable SAN FRANCISCO, Sept. 26, 2025  ― Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology ...

UVA Engineering team develops new way to build soft robots that can walk on water

2025-09-26
Imagine a tiny robot, no bigger than a leaf, gliding across a pond’s surface like a water strider. One day, devices like this could track pollutants, collect water samples or scout flooded areas too risky for people. Baoxing Xu, professor of mechanical and aerospace engineering at the University of Virginia’s School of Engineering and Applied Science, is pioneering a way to build them. In a new study published in Science Advances, Xu’s research introduces HydroSpread, a first-of-its-kind fabrication method that has great potential ...

Building trust in soil carbon as a climate solution requires stronger evidence

2025-09-26
In a comment published in Nature Climate Change, Mark Bradford, the E.H. Harriman Professor of Soils and Ecosystem Ecology, and Yale School of the Environment research scientists Sara Kuebbing and Alexander Polussa ’25 PhD, together with colleagues Emily Oldfield ’05, ’11 MESc, ’19 PhD, of Environmental Defense Fund (EDF) and Jonathan Sanderman of the Woodwell Climate Research Center, argue that the scientific evidence supporting soil carbon’s role in mitigating climate change ...

Blockchain technology could help build trust in restaurants

2025-09-26
While taste and price remain top priorities, more consumers are starting to consider the safety and sustainability of ingredients when dining out — a challenge that restaurants are working to address. To support this shift, researchers at the University of Missouri are investigating how a revolutionary technology that could allow consumers to track ingredients all along the supply chain will affect their decision-making processes. “Customers have become increasingly concerned about where their food is coming from, whether it’s sustainably sourced and how safe it is to eat,” Pei Liu, an associate professor of hospitality management in the College of Agriculture, ...

New study supports gene-tailored radiation doses to treat HPV+ throat cancer

2025-09-26
Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to Cleveland Clinic research. The study, published in the Journal of Clinical Investigation, builds on a growing body of evidence that radiation treatment can be personalized using tumor genomics, potentially shifting treatment approaches from the norm, where radiation is prescribed at a uniform dose, to one called Genomic Adjusted Radiation Dose (GARD), where radiation is prescribed to a desired effect.  The current standard radiation dose for HPV-positive throat cancer is 70 Grays (Gy), which offers cure rates between 80% and 95% but can ...

New adaptive optics to support gravitational-wave discoveries

2025-09-26
RIVERSIDE, Calif. -- Gravitational-wave detection technology is poised to make a big leap forward thanks to an instrumentation advance led by physicist Jonathan Richardson of the University of California, Riverside. A paper detailing the invention, published in the journal Optica, reports the successful development and testing of FROSTI, a full-scale prototype for controlling laser wavefronts at extreme power levels inside the Laser Interferometer Gravitational-Wave Observatory, or LIGO. LIGO is ...

Inactive H5N1 influenza virus in pasteurized milk poses minimal health risks

2025-09-26
(MEMPHIS, Tenn. – September 26, 2025) Proteins and genetic material from H5N1 influenza viruses have been found in pasteurized milk in the United States, but a study from St. Jude Children’s Research Hospital shows those inactive viral pieces represent little to no health risk. As the H5N1 outbreak in dairy cows continues in the U.S., commercial milk remains contaminated by viral pieces. However, the pasteurization process kills the virus. The researchers tested whether the resulting noninfectious ...

Geomagnetic disturbances caused by the Sun influence the occurrence of heart attacks, especially among women

2025-09-26
An article published in the journal Communications Medicine points to a correlation between disturbances in the Earth’s magnetic field resulting from solar storms and an increase in the frequency of heart attacks, especially among women. The authors reached this conclusion by analyzing data from the public health network of São José dos Campos, in the state of São Paulo, Brazil, recorded between 1998 and 2005, a period considered to be one of intense solar activity. Focusing on hospital admissions for myocardial infarction, the analysis included ...

Sylvester researchers to present findings at ASTRO 2025

2025-09-26
PRESIDENTIAL SYMPOSIUM SPEAKER: Classical Movement Disorders and Connectomics: Image-Guided Radiosurgery Reimagined Speaker: Markus Bredel, M.D., Ph.D., Sept. 28, 2025; 10:30-10:50 AM PT Location: San Francisco Ballroom   ORAL: Community Outreach Initiatives – Disparities in Gynecologic Cancer Care and Outcomes in the Age of Molecular Profiling and Targeted Therapies: Etiologies and Solutions Presenter: Amanda Rivera, M.D., Sept. 29, 2025, 11:32-11:47 AM PT Location: Room 154   ORAL: Pembrolizumab ...
Previous
Site 53 from 8593
Next
[1] ... [45] [46] [47] [48] [49] [50] [51] [52] 53 [54] [55] [56] [57] [58] [59] [60] [61] ... [8593]

Press-News.org - Free Press Release Distribution service.